GSK Investigational Site

Deszk 6772

0 studies enrolling now · 2 studies all time

What they study most

Lung Cancer, Non-Small Cell, Pulmonary Disease, Chronic Obstructive

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed